TipRanks
Go Ultimate55% OFF

Rayonier Advanced Materials (RYQ) Q2 2026 Earnings Report

DE:RYQ Q2 2026 EPS Results

Actual EPS
-EUR 0.27
Consensus EPS
-EUR 0.20
Beat/Miss
Missed by -EUR 0.07
One Year Ago EPS
-EUR 4.90

DE:RYQ Q2 2026 Revenue Results

Actual Revenue
EUR 336.80M
Expected Revenue
EUR 324.13M
Beat/Miss
Beat by +EUR 12.66M
YoY Revenue Growth
+10.61%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/04/2026
Time
After Close
Conference Call
Tuesday, August 4, 2026

Q2 2026 Earnings Call Audio

DE:RYQ Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 04, 2026|% Change Since:-24.00%|
Earnings Call Sentiment|Positive

The call described clear sequential operational and financial improvement (stronger sales, a meaningful uplift in adjusted EBITDA driven by Cellulose Specialties, improving cash generation and maintained liquidity and covenant compliance). Management emphasized an active, disciplined strategic review, operational improvement initiatives and a path to positive full-year free cash flow. Offsetting these positives are persistent weaknesses in Paperboard & High-Yield Pulp (negative EBITDA), pricing pressure in commodity grades, an impairment charge, elevated leverage and uncertainty from tariffs and trade proceedings. Overall, the tone is constructive and focused on execution with visible momentum, but material risks remain tied to refinancing, tariff outcomes and turnaround of weaker segments.

Company Guidance

Management reiterated that the strategic review remains a top priority and will be concluded with a clear path in Q4, and that the company remains on track to generate positive free cash flow for full‑year 2026 with the full‑year FCF trajectory aligned with prior expectations. They expect second‑half improvement driven by Cellulose Specialties—Q2 CS pricing was +21% year‑over‑year (+8% sequentially) with CS volumes +19% sequentially and management sees another ~10–15% volumes improvement in the back half—while cellulose commodities should see modest improvement and paperboard a firmer pricing outlook. Q2 results underpinning the guidance included net sales $376M (+18% seq, +11% YoY), adjusted EBITDA $40M (Q1 $8M; prior year $28M), HPC adjusted EBITDA $57M (19% margin), paperboard/high‑yield pulp net sales $75M (Adj. EBITDA -$10M), liquidity $145M (cash $57M, ABL $76M, France $12M), adjusted net debt $755M, net secured debt $726M and net secured leverage 4.2x vs a 4.75x covenant; YTD cash from operations $37M and YTD adjusted free cash flow -$8M (improved $57M YoY).

  • Strong Sequential and Year-over-Year Sales ImprovementNet sales of $376 million, up 18% sequentially and 11% year-over-year, driven primarily by the High Purity Cellulose (HPC) segment.
  • Adjusted EBITDA RecoveryCompany adjusted EBITDA increased to $40 million from $8 million in Q1 and $28 million in the prior year quarter (a 43% increase year-over-year). HPC adjusted EBITDA was $57 million (up $33 million sequentially and $12 million year-over-year).
  • HPC Pricing and Volume MomentumCellulose Specialties (CS) pricing rose 8% sequentially and 21% year-over-year; CS net sales $301 million (up $38 million sequentially and $29 million year-over-year). CS sales volumes improved 19% sequentially.
  • Operating and Commercial Action PlanNew CEO outlined a tangible pipeline of reliability, productivity and cost initiatives (energy efficiency, process optimization, automation) and focus on disciplined commercial execution and customer partnerships to drive value.
  • Improving Cash Generation TrajectoryYear-to-date cash provided by operations was $37 million, translating to adjusted free cash flow of negative $8 million (a $57 million improvement from negative $65 million prior year period). Company remains on track to generate positive free cash flow for full-year 2026 per guidance.
  • Liquidity and Covenant ComplianceTotal liquidity of $145 million (cash $57M; $76M availability under North American ABL; $12M France factoring). Net secured leverage 4.2x covenant EBITDA, inside the covenant test of 4.75x, and the company remained in compliance with all debt covenants.
  • Strategic Review and Management ExperienceComprehensive strategic review is active and expected to conclude in Q4; new CEO brings 35 years of operational and transaction experience and emphasized preservation of value and potential de-risked biomaterials interests (e.g., Altamaha Green Energy).

DE:RYQ Earnings History

DE:RYQ earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 03, 20262026 (Q3)0.00--0.06―
Aug 04, 20262026 (Q2)-0.20-0.27-4.994.57% (+4.63)
May 05, 20262026 (Q1)-0.56-0.55-0.44-24.29% (-0.11)
Mar 03, 20262025 (Q4)-0.07-0.25-0.09-175.00% (-0.16)
Nov 04, 20252025 (Q3)-0.06-0.06-0.1141.67% (+0.04)
Aug 05, 20252025 (Q2)-0.21-4.900.17-2978.95% (-5.07)
May 06, 20252025 (Q1)-0.08-0.44-0.02-2350.00% (-0.42)
Mar 05, 20252024 (Q4)-0.17-0.09-0.254.55% (+0.11)
Nov 05, 20242024 (Q3)-0.07-0.11-0.3670.00% (+0.25)
Aug 06, 20242024 (Q2)-0.090.17-0.22176.00% (+0.39)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More